Otezla 75 mg/1
apremilast · TABLET, FILM COATED · Amgen, Inc
No Recall History
Plain English
Otezla is a tablet, film coated containing apremilast at 75 mg/1, taken oral. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- Otezla
- Generic Name
- apremilast
- NDC Code (Product)
55513-519- Manufacturer
- Amgen, Inc
- Strength
- 75 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA205437
- Drug Class
- Phosphodiesterase 4 Inhibitor [EPC]
- Marketing Start
- 08/31/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Otezla used for?
Otezla contains apremilast. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Otezla a controlled substance?
Otezla is not classified as a controlled substance by the DEA.
What is the generic name for Otezla?
The generic name for Otezla is apremilast. There are no other listed brand versions of apremilast.
What is the NDC code for Otezla 75 mg/1?
The NDC (National Drug Code) for Otezla 75 mg/1 is 55513-519, listed by Amgen, Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)